Nova Patents
AT243198T

Frangible compounds for pathogen inactivation

Abstract

The invention claims a passivation material pathogen compound and method, pathogen composition and method for biological degradation material, wherein the material to red blood cell product and blood plasma. The compound and method can be used for treating the solution is (such as clinically steps or transfusion) is in form a material. The compound which is capable of performing a specific binding and reacting with a nucleic acid, and which the production by product. The degradation reaction is preferably is lower than the reaction rate of a nucleic acid.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

102 members in 11 offices

This recordMember, by publication datePriority claim1 more office is in the list below

Priority claims4

Priority claims
DocumentOfficeKindDate
77988597United States of AmericaA
77983097United States of AmericaA
4369697United States of AmericaP
9800532United States of AmericaW

Members102

Family members, oldest first
DocumentOfficeKind
CA2276532A1CanadaA1
CA2276747A1CanadaA1
WO9830327A1World Intellectual Property Organization (WIPO)A1
WO9830545A1World Intellectual Property Organization (WIPO)A1
AU5821798AAustraliaA
AU6021698AAustraliaA
CA2317430A1CanadaA1
CA2317603A1CanadaA1
CA2318508A1CanadaA1
WO9934839A1World Intellectual Property Organization (WIPO)A1
WO9934914A1World Intellectual Property Organization (WIPO)A1
WO9934915A1World Intellectual Property Organization (WIPO)A1
AU8289198AAustraliaA
AU8294998AAustraliaA
AU8295698AAustraliaA
EP0954374A1European Patent Office (EPO)A1
CN1248178AChinaA
CN1248245AChinaA
US6093725AUnited States of AmericaA
EP1021414A1European Patent Office (EPO)A1
EP1044066A1European Patent Office (EPO)A1
EP1045704A1European Patent Office (EPO)A1
EP1051249A1European Patent Office (EPO)A1
HK1026702A1Hong Kong, ChinaA1
CN1284886AChinaA
CN1284896AChinaA
CN1284897AChinaA
HK1028746A1Hong Kong, ChinaA1
JP2001508449AJapanA
JP2001508775AJapanA
US2001009756A1United States of AmericaA1
US6270952B1United States of AmericaB1
US2001018179A1United States of AmericaA1
HK1034682A1Hong Kong, ChinaA1
JP2002500204AJapanA
AU9714801AAustraliaA
AU744089B2AustraliaB2
US2002028432A1United States of AmericaA1
AU745209B2AustraliaB2
US2002045228A1United States of AmericaA1
US2002094568A1United States of AmericaA1
US6514987B1United States of AmericaB1
AU759541B2AustraliaB2
AU759966B2AustraliaB2
EP1021414B1European Patent Office (EPO)B1
AT243198TThis recordAustriaT
ATE243198T1AustriaT1
DE69815703D1GermanyD1
AU744089CAustraliaC
JP2003523777AJapanA
JP2003527230AJapanA
EP1364944A1European Patent Office (EPO)A1
ES2196530T3SpainT3
CN1132676CChinaC
CN1136042CChinaC
AU759966CAustraliaC
US2004029897A1United States of AmericaA1
US6709810B2United States of AmericaB2
CA2276747CCanadaC
CA2318508CCanadaC
DE69815703T2GermanyT2
AU773836B2AustraliaB2
US2004180321A1United States of AmericaA1
EP1045704B1European Patent Office (EPO)B1
US2004185544A9United States of AmericaA9
US2004185553A9United States of AmericaA9
AT276771TAustriaT
ATE276771T1AustriaT1
DE69826521D1GermanyD1
EP0954374B1European Patent Office (EPO)B1
AT283071TAustriaT
ATE283071T1AustriaT1
DE69827770D1GermanyD1
EP1508345A1European Patent Office (EPO)A1
ES2224415T3SpainT3
CN1203900CChinaC
US2005142542A1United States of AmericaA1
DE69826521T2GermanyT2
US6951713B2United States of AmericaB2
HK1073444A1Hong Kong, ChinaA1
DE69827770T2GermanyT2
US7037642B2United States of AmericaB2
US2006093999A1United States of AmericaA1
US7293985B2United States of AmericaB2
CA2276532CCanadaC
US7611831B2United States of AmericaB2
JP2010031049AJapanA
CN101676268AChinaA
JP2010095527AJapanA
US2010133160A1United States of AmericaA1
JP4551502B2JapanB2
JP2010248245AJapanA
JP4630405B2JapanB2
JP4643004B2JapanB2
CN1248245BChinaB
JP5244083B2JapanB2
CN101676268BChinaB
EP1508345B1European Patent Office (EPO)B1
ES2434319T3SpainT3
HK1188441A1Hong Kong, ChinaA1
Showing 100 of 102